Silencing of DLC1 upregulates PAI-1 expression and reduces migration in normal prostate cells

Molecular Cancer Research

Volumn 10, Issue 1, 2012, Pages 34-39

  Shih, Yi Ping ^a,b   Takada, Yoshikazu ^b   Lo, Su Hao ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PLASMINOGEN ACTIVATOR INHIBITOR 1;

ARTICLE; CELL MIGRATION; CONTROLLED STUDY; DELETED IN LIVER CANCER 1; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; MALE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION;

CELL MOVEMENT; CELLS, CULTURED; DOWN-REGULATION; EPITHELIAL CELLS; GENE EXPRESSION; GTPASE-ACTIVATING PROTEINS; HUMANS; MALE; MAP KINASE SIGNALING SYSTEM; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROSTATE; RECEPTOR, EPIDERMAL GROWTH FACTOR; RNA INTERFERENCE; RNA, SMALL INTERFERING; TUMOR SUPPRESSOR PROTEINS; UP-REGULATION;

EID: 84856020160     PISSN: 15417786     EISSN: 15573125     Source Type: Journal    
DOI: 10.1158/1541-7786.MCR-11-0450     Document Type: Article

References (22)

1. Yuan BZ, Miller MJ, Keck CL, Zimonjic DB, Thorgeirsson SS, Popescu NC. Cloning, characterization, and chromosomal localization of a gene frequently deleted in human liver cancer (DLC-1) homologous to rat RhoGAP. Cancer Res 1998;58:2196-9. (Pubitemid 28232908)
2. Liao YC, Lo SH. Deleted in liver cancer-1 (DLC-1): a tumor suppressor not just for liver. Int J Biochem Cell Biol 2008;40:843-7. (Pubitemid 351329658)
3. Durkin ME, Yuan BZ, Zhou X, Zimonjic DB, Lowy DR, Thorgeirsson SS, et al. DLC-1: a Rho GTPase-activating protein and tumour suppressor. J Cell Mol Med 2007;11:1185-207. (Pubitemid 350037059)
4. Liao YC, Shih YP, Lo SH. Mutations in the focal adhesion targeting region of deleted in liver cancer-1 attenuate their expression and function. Cancer Res 2008;68:7718-22.
5. Shih YP, Liao YC, Lin Y, Lo SH. DLC1 negatively regulates angiogenesis in a paracrine fashion. Cancer Res 2010;70:8270-5.
6. Goodison S, Yuan J, Sloan D, Kim R, Li C, Popescu NC, et al. The RhoGAP protein DLC-1 functions as a metastasis suppressor in breast cancer cells. Cancer Res 2005;65:6042-53. (Pubitemid 40994388)
7. Wong CM, Yam JW, Ching YP, Yau TO, Leung TH, Jin DY, et al. Rho GTPase-activating protein deleted in liver cancer suppresses cell proliferation and invasion in hepatocellular carcinoma. Cancer Res 2005;65:8861-8. (Pubitemid 41377375)
8. Zhang T, Zheng J, Jiang N, Wang G, Shi Q, Liu C, et al. Overexpression of DLC-1 induces cell apoptosis and proliferation inhibition in the renal cell carcinoma. Cancer Lett 2009;283:59-67.
9. Holeiter G, Heering J, Erlmann P, Schmid S, Jahne R, Olayioye MA. Deleted in liver cancer 1 controls cell migration through a Dia1- dependent signaling pathway. Cancer Res 2008;68:8743-51.
10. Jin Y, Tian X, Shang Y, Huang P. Inhibition of DLC-1 gene expression by RNA interference in the colon cancer LoVo cell line. Oncol Rep 2008;19:669-74. (Pubitemid 351330434)
11. Narumiya S, Tanji M, Ishizaki T. Rho signaling, ROCK and mDia1, in transformation, metastasis and invasion. Cancer Metastasis Rev 2009;28:65-76.
12. Liao YC, Si L, Devere White RW, Lo SH. The phosphotyrosine-independent interaction of DLC-1 and the SH2 domain of cten regulates focal adhesion localization and growth suppression activity of DLC-1. J Cell Biol 2007;176:43-9. (Pubitemid 46041679)
13. Qian X, Li G, Asmussen HK, Asnaghi L, Vass WC, Braverman R, et al. Oncogenic inhibition by a deleted in liver cancer gene requires cooperation between tensin binding and Rho-specific GTPase-activating protein activities. Proc Natl Acad Sci U S A 2007;104:9012-7. (Pubitemid 47175428)
14. Czekay RP, Loskutoff DJ. Unexpected role of plasminogen activator inhibitor 1 in cell adhesion and detachment. Exp Biol Med (Maywood) 2004;229:1090-6. (Pubitemid 39602250)
15. Kutz SM, Higgins CE, Samarakoon R, Higgins SP, Allen RR, Qi L, et al. TGF-beta 1-induced PAI-1 expression is E box/USF-dependent and requires EGFR signaling. Exp Cell Res 2006;312: 1093-105.
16. Zhong D, Zhang J, Yang S, Soh UJ, Buschdorf JP, Zhou YT, et al. The SAM domain of the RhoGAP DLC1 binds EF1A1 to regulate cell migration. J Cell Sci 2009;122:414-24.
17. Heering J, Erlmann P, Olayioye MA. Simultaneous loss of theDLC1 and PTEN tumor suppressors enhances breast cancer cell migration. Exp Cell Res 2009;315:2505-14.
18. Samarakoon R, Higgins CE, Higgins SP, Higgins PJ. TGF-beta1- induced expression of the poor prognosis SERPINE1/PAI-1 gene requires EGFR signaling: a new target for anti-EGFR therapy. J Oncol 2009;2009:342391.
19. Samarakoon R, Higgins PJ. Pp60c-src mediates ERK activation/ nuclear localization and PAI-1 gene expression in response to cellular deformation. J Cell Physiol 2003;195:411-20. (Pubitemid 36529868)
20. Ghosh AK, Vaughan DE. PAI-1 in tissue fibrosis. J Cell Physiol. 2011 Apr 4. [Epub ahead of print].
21. Yang X, Popescu NC, Zimonjic DB. DLC1 interaction with S100A10 mediates inhibition of in vitro cell invasion and tumorigenicity of lung cancer cells through a RhoGAP-independent mechanism. Cancer Res 2011;71:2916-25.
22. Lin Y, Chen NT, Shih YP, Liao YC, Xue L, Lo SH. DLC2 modulates angiogenic responses in vascular endothelial cells by regulating cell attachment and migration. Oncogene 2010;29:3010-6.